Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinomas of the Pancreas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02178436
What this trial is testing

Gemcitabine, Nab-paclitaxel and KPT-330 in Advanced Pancreatic Cancer

Who this might be right for
Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasStage IV Pancreatic Cancer
Mohammed Najeeb Al Hallak 15
Testing effectiveness (Phase 2)Looking for participantsNCT07306286
What this trial is testing

Cryoablation Combined With the Dual-Function Antibody PD-1/CTLA-4 for the Treatment of LAPC Following Failure of First-Line AG Therapy

Who this might be right for
Pancreatic Adenocarcinoma Locally Advanced
Ruijin Hospital 20
Not applicableUnknownNCT06342323
What this trial is testing

The Optimal Number of Fiducial Marker for Stereotactic Body Radiotherapy

Who this might be right for
Lung CancerLiver CancerPancreatic Cancer+1 more
Peking University Third Hospital 57
Testing effectiveness (Phase 2)Study completedNCT00536874
What this trial is testing

Gemcitabine and Oxaliplatin in Treating Patients With Pancreatic Cancer That Can Be Removed By Surgery

Who this might be right for
Pancreatic Cancer
Memorial Sloan Kettering Cancer Center 39
Testing effectiveness (Phase 2)UnknownNCT00010088
What this trial is testing

Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas or Bile Duct

Who this might be right for
Extrahepatic Bile Duct CancerPancreatic Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group
Early research (Phase 1)Study completedNCT00039403
What this trial is testing

UCN-01 and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic Cancer

Who this might be right for
Adenocarcinoma of the PancreasRecurrent Pancreatic CancerStage II Pancreatic Cancer+2 more
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Ended earlyNCT00766636
What this trial is testing

Preoperative Chemotherapy (Gemcitabine and Erlotinib) With or Without Radiation Therapy

Who this might be right for
Pancreatic Cancer
M.D. Anderson Cancer Center 5
Large-scale testing (Phase 3)Study completedNCT00960284
What this trial is testing

Gemcitabine or Combination Chemotherapy Followed by Chemoradiation for Stage IB, II, or III Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
IRCCS San Raffaele 102
Large-scale testing (Phase 3)Looking for participantsNCT07087054
What this trial is testing

Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen

Who this might be right for
Carcinoid SyndromeCarcinoidCarcinoid Tumor+6 more
Crinetics Pharmaceuticals Inc. 141
Testing effectiveness (Phase 2)Looking for participantsNCT05431270
What this trial is testing

Dose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 mAb, Administered Alone and in Combination With a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study)

Who this might be right for
Non Small Cell Lung CancerPancreatic Ductal Adenocarcinoma
Phanes Therapeutics 40
Early research (Phase 1)Not Yet RecruitingNCT07807956
What this trial is testing

Assess Adverse Events, Change in Disease Activity and How Intravenous ABBV-253 Moves Through the Body in Adult Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsNon-Small Cell Lung CancerColorectal Cancer+6 more
AbbVie 130
Not applicableLooking for participantsNCT01365169
What this trial is testing

Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"

Who this might be right for
Malignant Head and Neck NeoplasmMalignant NeoplasmMetastatic Malignant Neoplasm in the Neck+45 more
M.D. Anderson Cancer Center 590
Large-scale testing (Phase 3)Study completedNCT00044031
What this trial is testing

Safety and Efficacy of G17DT Immunogen Combined With Gemcitabine vs. Gemcitabine in the Treatment of Advanced Pancreatic Carcinoma

Who this might be right for
Pancreatic Cancer
Cancer Advances Inc. 394
Testing effectiveness (Phase 2)Study completedNCT00962312
What this trial is testing

Lapatinib Ditosylate and Capecitabine in Treating Patients With Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Cancer Trials Ireland 9
Not applicableUnknownNCT05043532
What this trial is testing

Randomized Trial for Optimal Number of Passes Required for Molecular Profiling During EUS-FNB of Pancreatic Cancer

Who this might be right for
Pancreatic CancerPancreatic NeoplasmsAdenocarcinoma of the Pancreas
Orlando Health, Inc. 33
Testing effectiveness (Phase 2)Study completedNCT00203892
What this trial is testing

Study of CAP1-6D in Patients With Locally Advanced or Surgically Resected Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Adenocarcinoma
University of Chicago 23
Testing effectiveness (Phase 2)Active Not RecruitingNCT05922930
What this trial is testing

Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells Delivered Intraperitoneally for the Management of Platinum Resistant Ovarian Cancer, Mesonephric-like Adenocarcinoma, and Pancreatic Cancer

Who this might be right for
Pancreatic CancerOvarian CancerAdenocarcinoma
M.D. Anderson Cancer Center 51
Testing effectiveness (Phase 2)WithdrawnNCT04045730
What this trial is testing

The Study of Gemcitabine Plus Nab-Paclitaxel in Combination With Pegvorhyaluronidase Alfa (PVHA; PEGPH20) and Pembrolizumab as Front-line Treatment for Metastatic Pancreatic Adenocarcinoma.

Who this might be right for
Pancreas Adenocarcinoma
Yale University
Early research (Phase 1)Looking for participantsNCT06508307
What this trial is testing

A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patient With Advanced Solid Tumors

Who this might be right for
SarcomaCervical CancerColon Cancer+6 more
GONGCHU Biotechnology Co., Ltd 21
Early research (Phase 1)Study completedNCT01298401
What this trial is testing

Ganitumab and Gemcitabine Hydrochloride Followed by Radiation Therapy, Ganitumab, Capecitabine, and Maintenance Therapy in Treating Patients With Locally Advanced Cancer of the Pancreas

Who this might be right for
Pancreatic Cancer
Radiation Therapy Oncology Group 8
Next Page